At a glance
Read the record in context
The GHK-Cu card pairs a large catalog mass with a poorly characterized systemic model. Its 50 mg vial does not strengthen the evidence for a half-hour injectable input. Topical references, endogenous-tripeptide context, and supplier packaging each need to retain their own meaning.[1]
What the research says
The cited review examines GHK and its copper complex in skin repair research. It brings together cell experiments, animal wound models, and topical human observations. Laboratory endpoints include collagen and glycosaminoglycan production, matrix-remodeling enzymes, fibroblast activity, and gene-expression changes rather than one common clinical outcome.[2]
Animal studies discussed in the review include wound-healing experiments in rodents and other species. The human cosmetic literature concerns topical application and measurements such as skin density, firmness, and appearance. Those settings differ substantially from measuring the systemic disposition of an injected copper-peptide preparation.[2][1]
The review supports the identity of GHK as a naturally occurring tripeptide with copper-binding properties. It does not supply a well-characterized human injectable half-life for the library's model. The half-hour estimate remains a low-confidence tracking assumption alongside the more directly described skin and cell research.[2][1]
Cited amounts
The library records 50 mg as a supplier catalog package amount. This is the total listed in that presentation, not an amount selected for administration. No personal dosing range is inferred from it.[1][3]
Explore the GHK-Cu dosing chartHalf-life and timing
Starting from 0.5 hours, the displayed fractions reach 25% at one hour and 12.5% at 90 minutes. Five intervals end at 2.5 hours with 3.125% of the starting quantity left. Nothing in this arithmetic resolves the library's lack of well-characterized systemic injectable data. The smooth sequence is a consequence of a chosen constant, not a new experiment. It also cannot translate topical-use research into a personal injection timetable or describe how a topical preparation behaves on skin.[1][5]
Explore the GHK-Cu half-life modelReconstitution
The supplier's 50 mg listing is ten times a 5 mg package, but the formula itself is unchanged. At a hypothetical final volume of 2 mL, concentration is 25 mg/mL. An illustrative 0.1 mL represents 2.5 mg. Those values demonstrate scaling a mass-volume calculation, not selecting an injectable amount. A large total on a catalog label is not a reason to assume a clinical amount or preparation method, and the example adds no missing evidence about systemic exposure.[3]
Tracking it in PinPoint
From a reference to a record
Built for peptide, TRT, and GLP-1 schedules. Set up your vial in seconds, log every dose, and see your modeled levels between doses. Enter vial size in mg, mcg, or IU and water volume for instant concentration and syringe units. Track vials and prefilled pens side by side.[4]
The Home curve models your levels between doses from published half-life data. Drag to scrub modeled values at any timestamp, or preview 30 days of a dose pattern. Ask PinPoint provides educational reference with sources; it never recommends a dose or a schedule change. These features record and visualize entered information, with the limits of each compound's source data still applying.
Get PinPoint on the App StoreFrequently asked questions
- What does GHK-Cu injection dosage research establish here?
- The library says systemic injectable model data are poorly characterized. Its topical and review references do not establish a human injection amount. The guide can explain the 50 mg package example and its conversion arithmetic without presenting that total as a clinical dose.[1][2]
- Can a GHK-Cu dosage calculator bridge topical and injectable research?
- The calculator only manipulates entered units and volumes. It cannot establish that evidence for one route characterizes another. The library explicitly separates better-described topical literature from poorly characterized systemic injectable modeling.[1][5]
- Why is the 50 mg GHK-Cu catalog total shown at all?
- It supplies a transparent origin for the arithmetic example. The catalog is labeled as a package source so its quantity is not mistaken for a human research amount. Readers can trace the number without treating the listing as clinical evidence.[1][5]
- Can a peptide tracker app record GHK-Cu?
- PinPoint's compound library includes GHK-Cu. The app description covers logging compound, dose, site, and pain level, as well as viewing modeled levels between recorded doses. The curve uses published reference inputs and does not account for individual variation. The tracker records the schedule entered by its user; it does not choose a dose or recommend a schedule change.[1][4]
Sources
Facts and reference links were retrieved from the PinPoint application library on 5 October 2026. Links below preserve the library's citations; a catalog source supports a package amount only. Source references carried from the library have not all been independently reverified. Arithmetic examples are identified separately from clinical evidence.
- PinPoint compound library, GHK-CuSnapshot of the application library; its references and uncertainty are retained below.Retrieved 2026-10-05 · library
- Published review PMC4508379Identity and research summary checked against this document on 5 October 2026. Abstract and relevant methods/results or product-monograph sections.Retrieved 2026-10-05 · library-reference
- Supplier catalog package referencePackage amount only; not a clinical amount or endorsement.Retrieved 2026-10-05 · supplier
- PinPoint App Store descriptionFeature wording from the approved application description, not pricing.Retrieved 2026-10-05 · app-description
- Unit conversion and exponential-decay arithmeticC = amount / volume; remaining fraction = 2^(-elapsed / half-life). These are illustrations, not measurements.Retrieved 2026-10-05 · arithmetic